．．hol．aáloae．、－．βo．βera．trＲ、．βldc．d．．．、llae－－i．e－r－il、a、r②inat、p、、r．Ｒ－．．－．ttü．rpma－－．、ailm．e．。βlro．a．。e．．lrm①o。tc、．mad、ipsrx、③、r·。q．．、－．l、ea．。ae．－．、meiehils．。．v．i．。r．－．l－todβao．ltlt．、．odalmlt－－、．．。．．tahe·。Ｒ．odaroe．h
ChinHeartJ2013256745
CM
VMC
VMC
MHCADP/ATP
ANT
11
M41KytVSarasteAVoipio-PulkkiLMIncidenceoffatalmy-
2
8
ocarditisapopulation-basedstudyinFinlandJAJE
VMC
20071655570574
31
242
22.6%77.4%85VMC
J20091675152
55.3%MHC27ANT
3CooperLTBaughmanLKFeldmanAMTheroleofendom-
2732M41
12
yocardialbiopsyinthemanagementofcardiovasculardiseaseAsci-
VMC
entificstatementfromtheAmericanheartassociationtheAmerican
MHCCollegeofCardiologyandtheEuropeanSocietyofCardiologyJ
JACC2007501919141931
4OlimulderMAvanEsJGaljeeMATheimportanceofcardiac
ANT
1
MIasadiagnostictoolinviralmyocarditis-inducedcardiomyopathy
M
2
JNHJ20091712481486
MHC
5
ANTM
12
J2011113273277
VMC
6FriedrichMGSechtemUSchulz-MengerJCardiovascular
magneticresonanceinmyocarditisAJACCWhitePaperJJA
CC2009531714751487
7BratincskAEl-SaidHGBradleyJSFulminantmyocardi-
4
tisassociatedwithpandemicH1N1influenzaAvirusinchildren
VMC
JJACC2010559928929
8
J2012717576
9
J2011334449
9
VMC451
2013-03-262013-05-14
1999
741
2013312108114
9
12ZorluAYcelHYontarOCEffectoflevosimendaninpa-
J2012122344644466
tientswithseveresystolicheartfailureandworseningrenalfunction
10afouli-StergiouPParissisJTAnastasiou-NanaMInotropesfor
JABC2012986537843
themanagementofacuteheartfailurepatientswithrenaldysfunc-
13J
tionStillanoptionJEOP201213
201046789792
1826372647
14J
11HouZQSunZXSuCYEffectoflevosimendanonesti-
2011323382385
matedglomerularfiltrationrateinhospitalizedpatientswithdecom-
2013-04-102013-06-20
pensatedheartfailureandrenaldysfunctionJCT |
|
